Zydus Lifesciences is set to acquire Agenus Inc.'s biologics manufacturing facilities in California for $75 million upfront ...

Agenus (NASDAQ:AGEN) stock surges 21% after partnering with Zydus Lifesciences for cancer therapies, botensilimab and ...

Concord Biotech share price rose on the back of a healthy March quarter of financial year 2025 (Q4FY25) results.

Bharat Biotech to launch Hillchol, its oral cholera vaccine, amid a global shortage. With Phase III trials completed and 200M ...

In this study, participants were divided into three age groups: adults over 18 years, children aged 5 to under 18 years, and ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...

Hyderabad-based Bharat Biotech International Ltd. has claimed that its oral cholera vaccine (OCV) under development, Hillchol ...

The move will enable the company to strengthen its foothold in the US and establish its presence in the fast-growing global ...

Excerpted with permission from Our Future is Biotech: A Plain English Guide to How a Tech Revolution is Changing Our Lives ...

Bharat Biotech's Hillchol OCV, effective against cholera serotypes, aims to provide affordable, accessible vaccines for ...

Since Trump’s re-election in November, the Trump Organization — his family’s real estate empire — has announced 12 new ...

Bharat Biotech’s oral cholera vaccine, Hillchol, aims to ease a critical global shortfall, with the world currently lacking ...